Most pharmacists may be aware that there is a current shortage of Clomiphene 75mg, a drug used for anovulatory infertility
Due to this shortage, we have seen several reports where serious dispensing error have occurred where pharmacies try to find a solution and dispense a wrong molecule.
On more than one occasion, a pharmacist has substituted Clomipramine 25mg with instructions to take three tablet (75mg) thinking this is the same drug as Clomiphene. The implications of this error are twofold.
By inadvertently taking Clomipramine which is a tricyclic antidepressant, all the usual side effects such as dry mouth, blurred vision and sedation to name a few will be experienced.
Also, a missed conception in a treatment cycle can be both distressing for the consumer and costly for the pharmacist and his insurers. When treatment by an IVF clinic and a dispensing error are mentioned in the one sentence, the implications can be enormous due to the high costs involved.
As Clomid (Clomiphene 75mg) is commercially unavailable at present, some compounding pharmacies are able to manufacture an equivalent product. This can only be done with the permission of both the prescriber and the consumer and the manufactured product cannot be labelled or referred to as Clomid. In normal circumstances, a commercially manufactured product such as Clomid cannot be compounded as per the Pharmacy Board of Australia guidelines on compounding.
The PDL Professional Liabilities Insurance (PI) policy provided through PDL meets the requirements of your National Board’s registration standard for compounding pharmacists.
Call PDL on 1300 854 838 or click here